Zelta by Merative

When facing the prospect of growing data management costs and user dissatisfaction, X4 Pharmaceuticals took a radically human-centric approach to solve their #clinicaldata management problems. And it paid off. Check out our new blog post highlighting X4’s success story – how they partnered with Zelta to create a central, cross-organizational, collaborative vision that empowered stakeholders across the #clinicaldevelopment spectrum, and how this strategy created seamless data exchange and real-time problem-solving across the organization, all leading to a remarkable 40% reduction in annual #datamanagement costs and skyrocketing user satisfaction. https://lnkd.in/erwvHJfS

You may already know full well how important randomization is to running #clinicaltrials – but have you ever considered enrolling your participants’ teeth to randomize the trial? You don’t want to miss this week’s webinar with Solventum, where we’ll explore how they were able to successfully reduce selection bias using a novel, teeth-centric approach to randomization, and how a flexible #EDC platform like Zelta helps to enable innovation solutions like these to meet the unique needs of your clinical trials. Don’t miss this conversation. Register for the webinar today! https://lnkd.in/eGDTBj7Y

Zelta empowers #CROs and #sponsors to build #clinicaltrial studies faster, enjoy new levels of flexibility, and reap cleaner data from their studies. But you don’t need to take our word for it. This month we’re spotlighting success stories from a few high-profile Zelta users: Alira Health, Integrated Therapeutic Solutions Inc., Poseida Therapeutics, Inc., and Vogenx, Inc. Check out their stories of how Zelta has helped transform their clinical trials with significant time and cost savings, cleaner databases, and seamless self-service support. https://lnkd.in/eSrXxNDs

You know better than anyone that sometimes what’s best for building #clinicaltrials is out-of-the-box thinking. An effective randomization strategy is essential to robust trial design is, but traditional methods aren’t always the best fit. Join Krista Dahling, Supervisor of Clinical Data Management for Solventum, and Jennifer Duff, General Manager of Zelta, for an insightful discussion on how an innovative approach to clinical trial randomization used teeth to successfully reduce selection bias, and how Zelta helps enable novel solutions like these. Book your spot for the webinar: https://lnkd.in/eGDTBj7Y

It's day 2 of #SCDM24! If you're looking for an all-in-one #EDC platform that scales across phase I to III trials, with built-in support for ePRO, eCOA, RTSM, medical coding with #AI, and more, then stop by booth #114. We'll be happy to show you with your own private demo of how the Zelta platform has helped sponsors and CROs like you to accelerate over 4,200 worldwide clinical trials with control and confidence. https://lnkd.in/eGGgWWi8

We're here for day 1 of #SCDM24! Don't miss our joint session with X4 Pharmaceuticals this afternoon for an engaging presentation about how they leveraged Zelta to reduce their annual data management costs by 40%. And while you're here, visit booth #114 for a one-on-one conversation about how Zelta can help you meet your own data management goals. https://lnkd.in/eGGgWWi8

We’re excited to announce that Zelta has been ranked a Leader in the Everest Group's inaugural EDC Products PEAK Matrix® Assessment! This follows a year of momentum that saw the Zelta platform surpass 4,200 clinical trial studies. And it validates our track record of providing market-leading clinical solutions for over a decade, with support for over 500 phase III trials, executed in over 100 countries around the world. Read more about Everest Group’s evaluation and how it supports Zelta’s #EDC platform for building and managing #clinicaltrial studies. https://lnkd.in/egs5FsPz

#SCDM24 starts this weekend! But it’s not too late to book a meeting to learn about how Zelta is empowering CROs, sponsors, and pharma and biotech companies like yours to accelerate #clinicaltrials and bring treatments to market faster. With a cloud-based platform that can seamlessly adapt to phase I-III trials, #AI and #ML that can scale across trials of all phases, and support for capabilities like local labs, #eCOA, #ePRO, eConsent, #RTSM, and more, there’s a reason why Zelta has been used to support over 4,100 clinical trials around the world. Meet us at booth #114 to learn more Zelta can do the same for your studies. Book your meeting below. https://lnkd.in/eGGgWWi8

At a time when #AI and #MachineLearning are dominating the narrative in clinical research, X4 Pharmaceuticals has taken a fundamentally different approach to revolutionizing #clinicaldata management. Join our session at #SCDM24 with Matthew Dame, senior director of clinical data management for X4, to learn how X4 achieved a 40% reduction in their annual data management costs with Zelta’s clinical data management platform. If you can’t make the session, or want to continue the conversation about how Zelta can help you achieve your data management goals, visit us at booth #114 or make a plan to meet with us below. See you there! https://lnkd.in/eGGgWWi8

Listen to Katrina Riggs, MSHS, CCRA, COO of Fast-Track Drugs & Biologics, LLC, share how her team has leveraged Zelta’s #ePRO capabilities and self-service support to accelerate #clinicaltrials with dozens of patient-reported outcomes, and how the platform has helped put their clients’ data management needs and drug development processes on the fast track. https://lnkd.in/eMTfH9_5